Sg3 Management, LLC Reata Pharmaceuticals Inc Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $153,045 - $276,930	-1,500 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$93.53 - $163.34 $140,295 - $245,010	1,500 New	1,500 $146,000
Q1 2020 May 12, 2020	SELL	$124.16 - $247.74 $496,640 - $990,960	-4,000 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$74.57 - $217.92 $186,424 - $544,800	2,500 Added 166.67%	4,000 $818,000
Q1 2019 May 14, 2019	BUY	$51.9 - $101.79 $77,850 - $152,685	1,500 New	1,500 $128,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.